↓ Skip to main content

Pharmacogenomics in Drug Discovery and Development

Overview of attention for book
Cover of 'Pharmacogenomics in Drug Discovery and Development'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 From Pharmacogenomics and Systems Biology to Personalized Care: A Framework of Systems and Dynamical Medicine
  3. Altmetric Badge
    Chapter 2 Translational Bioinformatics Approaches for Systems and Dynamical Medicine
  4. Altmetric Badge
    Chapter 3 Whole Blood Transcriptomic Analysis to Identify Clinical Biomarkers of Drug Response
  5. Altmetric Badge
    Chapter 4 Diagnostic Procedures for Paraffin-Embedded Tissues Analysis in Pharmacogenomic Studies
  6. Altmetric Badge
    Chapter 5 Approach to Clinical and Genetic Characterization of Statin-Induced Myopathy
  7. Altmetric Badge
    Chapter 6 Pharmacogenetics of membrane transporters: a review of current approaches.
  8. Altmetric Badge
    Chapter 7 G protein-coupled receptor accessory proteins and signaling: pharmacogenomic insights.
  9. Altmetric Badge
    Chapter 8 G protein-coupled receptor mutations and human genetic disease.
  10. Altmetric Badge
    Chapter 9 Pharmacogenetics of the g protein-coupled receptors.
  11. Altmetric Badge
    Chapter 10 Pharmacogenomics of Heart Failure
  12. Altmetric Badge
    Chapter 11 Pharmacogenomics in the Development and Characterization of Atheroprotective Drugs
  13. Altmetric Badge
    Chapter 12 Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neuropathy
  14. Altmetric Badge
    Chapter 13 Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development.
  15. Altmetric Badge
    Chapter 14 Pharmacogenetics of antipsychotic treatment in schizophrenia.
  16. Altmetric Badge
    Chapter 15 Pharmacogenetics of addiction therapy.
  17. Altmetric Badge
    Chapter 16 Pharmacogenetics in Rheumatoid Arthritis
  18. Altmetric Badge
    Chapter 17 Pharmacogenomics of Osteoporotic Fractures
  19. Altmetric Badge
    Chapter 18 Pharmacogenomics and Pharmacoepigenomics in Pediatric Medicine
  20. Altmetric Badge
    Chapter 19 Pharmacogenomics in Children
Attention for Chapter 15: Pharmacogenetics of addiction therapy.
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Pharmacogenetics of addiction therapy.
Chapter number 15
Book title
Pharmacogenomics in Drug Discovery and Development
Published in
Methods in molecular biology, January 2014
DOI 10.1007/978-1-4939-0956-8_15
Pubmed ID
Book ISBNs
978-1-4939-0955-1, 978-1-4939-0956-8
Authors

David A Nielsen, Ellen M Nielsen, Teja Dasari, Catherine J Spellicy, David A. Nielsen, Ellen M. Nielsen, Catherine J. Spellicy, Nielsen, David A., Nielsen, Ellen M., Dasari, Teja, Spellicy, Catherine J.

Abstract

Drug addiction is a serious relapsing disease that has high costs to society and to the individual addicts. Treatment of these addictions is still in its nascency, with only a few examples of successful therapies. Therapeutic response depends upon genetic, biological, social, and environmental components. A role for genetic makeup in the response to treatment has been shown for several addiction pharmacotherapies. For several addiction pharmacotherapies, response to treatment varies based on individual genetic makeup. In this chapter, we discuss the role of genetics in pharmacotherapies, specifically for cocaine, alcohol, and opioid dependences. The elucidation of the role of genetics should aid in the development of new treatments and increase the efficacy of existing treatments.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 47 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 13%
Researcher 6 13%
Student > Master 5 11%
Student > Bachelor 3 6%
Librarian 3 6%
Other 9 19%
Unknown 15 32%
Readers by discipline Count As %
Medicine and Dentistry 10 21%
Biochemistry, Genetics and Molecular Biology 6 13%
Pharmacology, Toxicology and Pharmaceutical Science 5 11%
Neuroscience 5 11%
Nursing and Health Professions 2 4%
Other 4 9%
Unknown 15 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 August 2014.
All research outputs
#20,235,415
of 22,761,738 outputs
Outputs from Methods in molecular biology
#9,864
of 13,088 outputs
Outputs of similar age
#264,835
of 305,286 outputs
Outputs of similar age from Methods in molecular biology
#404
of 596 outputs
Altmetric has tracked 22,761,738 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,088 research outputs from this source. They receive a mean Attention Score of 3.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 305,286 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 596 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.